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a b s t r a c t
The large T antigen (LT) protein of JCV and SV40 polyomaviruses is required to induce tumors in rodents
and transform cells in culture. When both LTs are compared side-by-side in cell culture assays, SV40
shows a more robust transformation phenotype even though the LT sequences are highly conserved.
A complete understanding of SV40's enhanced transforming capabilities relative to JCV is lacking. When
the least conserved region of the LT proteins, the variable linker and host range region (VHR), was
removed, changes in T antigen expression and cellular p53 post-translational modiﬁcations occurred, but
interaction with the pRB pathway was unaffected. Transformation assessed by growth in low serum was
reduced after VHR truncation of the SV40, but not the JCV, T antigen. Conversely, anchorage independent
transformation was enhanced only by truncation of the JCV VHR. This is the ﬁrst report to link the SV40
or JCV VHR region to transformation potential.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Polyomaviruses are a group of small, double-stranded DNA viruses
with an icosahedral capsid that lacks an envelope. Over 40 polyoma-
viruses have been identiﬁed in multiple species, ranging from mam-
mals to birds, and even amphibians and reptiles. The majority of
human polyomaviruses (PyV) do not cause disease in healthy indivi-
duals, but some are the cause of disease when the immune system is
compromised. One of the most studied disease-associated with
polyomaviruses is the human JC virus (JCV). A signiﬁcant percent of
the population is seropositive for JCV, however subsequent disease is
overwhelmingly associated with immunocompromised individuals
(Hirsch et al., 2013). In an immunocompromised setting, JCV can
actively infect the central nervous system, causing progressive multi-
focal leukoencephalopathy as a result of the destruction of glial tissue
in the brain. This disease is fatal, since few effective treatments are
available. JCV is closely related to the primate polyomavirus SV40
(Pipas, 1992), which is considered the model virus of this group. Since
its discovery in 1960 (Eddy et al., 1961), the study of SV40 has
facilitated the understanding of many basic viral and cellular functions
including DNA replication, cell cycling, and transcriptional control of
gene expression (Howley and Livingston, 2009).
All polyomaviruses share a similar genome structure, where a large
non-coding region physically and temporally separates and controls
the expression of the early and late transcribed regions of the genome.
The early transcribed region (ER) is alternatively spliced to create at
least two transcripts translated into a large T antigen and a small
T antigen protein. The large T antigen (LT) is a multi-functional, multi-
domain protein responsible for the replication of the viral genome as
well as for the manipulation of the host cell environment to produce
conditions conducive to replication (An et al., 2012; Topalis et al.,
2013). The small T antigen (sT) and various other T antigen proteins
also contribute indirectly to genome replication and directly to
environmental manipulation (Khalili et al., 2008; Bollag et al., 2010;
Prins and Frisque, 2001). Later in infection, transcription of the right
arm of the genome, or late region, is activated and viral capsid and exit
facilitator proteins are expressed, which are necessary to generate a
productive infection.
Some PyVs exhibit transformation potential only when expressed
in a non-native host system (SV40, JCV, BKV, African green monkey
PyV), while others induce tumor formation in the natural host
(Merkel cell PyV (Arora et al., 2012; Spurgeon and Lambert, 2013),
murine PyV, and hamster PyV) (Kean and Garcea, 2009). Transforma-
tion normally requires the expression of the LT, except for murine
and hamster PyVs in which the middle T antigen is essential (Cheng
et al., 2009). The current model of polyomavirus LT induced
transformation of cells is based on studies with SV40 LT and has
been reviewed extensively (An et al., 2012; Cheng et al., 2009; Pipas,
2009). Mutational analysis of SV40 LT has shown that elements
required for transformation include the J domain, LxCxE motif, and
ATPase domain (see Fig. 1A for domain structure of LT). The LxCxE
motif and J domain are required to bind cellular pRB proteins and
release E2F transcription factors, respectively, from an inhibitory
complex with pRBs. Once E2Fs are free, they trigger expression of
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genes involved in cell cycling and proliferation. Both the ectopic
proliferation and DNA damage induced directly by SV40 LT activate
p53, a master regulator of cell-cycle checkpoints and inducer of cell
death. Surface residues on the ATPase domain of SV40 LT bind and
block the p53 DNA-binding domain, preventing transcriptional
activation of p53-responsive genes and resulting in unchecked
growth and transformation in SV40 LT-expressing cells.
JCV and SV40 have been shown to cause tumors in rodent animal
models and transformation of cells in culture, and both LTs are
necessary and sometimes sufﬁcient to induce tumorigenesis by
targeting both pRB and p53 (Pipas, 2009; Frisque et al., 2006). In spite
of this similarity, SV40 T antigen is more efﬁcient than JCV T antigen in
side-by-side comparisons of transformation ability (Hayashi et al.,
2001; Bollag et al., 1989; Haggerty et al., 1989; Trowbridge and Frisque,
1993; Tavis et al., 1994). The reason for this difference has yet to be
fully deﬁned. A comparison of the amino acid sequences reveals that
JCV LT is about 70% identical to SV40 LT, and that they are up to 80%
identical in speciﬁc shared functional domains (Fig. 1A). Interestingly,
the short C-terminal section immediately following the ATPase
domain, known in SV40 LT as the variable linker and host range
region (VHR), shows the least similarity between both LTs (Fig. 1A
and C). We hypothesized that JCV LT VHR does not have the same
biological functions as SV40 LT VHR due to structural disparity. We
describe here the effects on cellular transformation produced by
removing the VHR from JCV and SV40 T antigens.
Results
Establishment of a system to compare the early regions of SV40
and JCV
We cloned full length (SV40.ER and JCV.ER) and VHR-truncated
(SV40.ERΔVHR or JCV.ERΔVHR) early regions for both SV40 and
JCV into the same expression vector. All four constructs were
introduced into murine embryonic ﬁbroblasts (MEFs), and pools of
cells that survived selection were collected. We compared the
ability of VHR truncated early regions to transform with the full
length counterparts. Three individual pools of cells were generated
and tested for each construct to ensure that the observed pheno-
types within an individual pool were not random.
The early regions of both SV40 and JCV are capable of produ-
cing multiple protein products through alternative splicing
mechanisms (Fig. 2A) (Trowbridge and Frisque, 1995; Zerrahn
et al., 1993). Truncation of the JCV early region removes 30 splice
acceptor sites for T0165 and T0136 introns, ultimately preventing
the corresponding proteins from being made. In addition, deletion
of the VHR shortens the LT proteins to 625 and 626 aa in SV40 and
JCV, respectively (Fig. 1B), causing a shift in apparent molecular
size from 94 to 70 kD (Fig. 2B). Table 1 lists the expected
protein products from each construct.
Removal of the VHR alters the pattern of SV40 and JCV early region
protein expression
We ﬁrst determined the protein and messenger RNA expres-
sion of T antigen products in each pool of cells by western blot and
RT-PCR, respectively. In SV40.ER expressing cells LT was the
dominant product identiﬁed at both the protein and mRNA levels
(Fig. 2B, lanes 1–3; Fig. 2C and D, SV40.ER lanes). Small T protein
was only detected after a long exposure (Fig. 2B lanes 1–3), and
the level of sT mRNA was lower than LT mRNA (Fig. 2D, SV40.ER
lanes). LT protein expression was reduced when the VHR was
removed from the SV40 early region, while sT protein expression
increased (Fig. 2B lanes 4–6). The altered levels of LT and sT
protein could not be attributed to changes in mRNA transcripts
since there was no detectable difference in LT or sT transcripts
between cell pools expressing SV40.ER and SV40.ERΔVHR (Fig. 2C
Fig. 1. Structure and similarity of large T antigens. (A) Structure of the large T antigen protein. Functional domains (rectangles) within large T are depicted. The functions and
percent amino acid identity (gray bar) of each domain within SV40 and JCV large T are indicated above the diagram. At the N-terminus are the DNA J domain and linker
region, which are both required to fully inhibit pRB activity. The origin binding domain is required for viral genome replication. The zinc binding domain and the ATPase
domain together contribute to the helicase activity of large T. Cellular p53 binds large T through surface residues of the ATPase domain. The variable linker region and host
range region are poorly characterized in comparison to the other regions of large T. (B) Structure of the large T antigen expressed from ERΔVHR constructs. The variable
linker and host range regionwas removed from each TAg gene by PCR. These constructs express amino acids 1-625 of SV40 large T or amino acids 1-626 of JCV large T as well
as other T antigen proteins (discussed in the Results section). (C) Protein sequence comparison of SV40 and JCV VHR regions. An alignment of amino acids was performed
with LALIGN. The host range region of SV40 is highlighted in red letters, and was used to deﬁne the boundaries of the JCV host range region. Previously described motifs and
post-translational modiﬁcation sites are shown (described in the Discussion section).
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and D, compare SV40.ER and SV40.ERΔVHR lanes). In preliminary
experiments, we observed only a slight decrease in the half-life
between full length and VHR truncated-LT protein (data not
shown). This suggests that the stability of the protein was not
signiﬁcantly altered and should not account for the drastic
decrease of SV40 LT protein in SV40.ERΔVHR cells.
We were unable to detect the SV40 17kT protein. This is not
surprising, since the level of 17kT transcript was either extremely
low or undetected in multiple experiments performed with all
SV40-expressing pools (Fig. 2C and data not shown).
Unlike with SV40, LT was not the dominant protein seen in cells
expressing the full length JCV early region. Rather, smaller
T antigen proteins (sT, T0135, T0136, T0165) were expressed in the
highest abundance (Fig. 2B, lanes 7–9), and this was reﬂected in
the mRNA expression. The T0 transcripts were so abundant that we
could not detect LT or sT transcripts using a set of primers that
amplify all T antigen transcripts (Fig. 2A, primers E and B; Fig. 2C,
JCV ER lane). The inability to detect JCV LT and sT transcript was
mostly likely because T0 transcripts absorbed most of the primers
during PCR ampliﬁcation. To address this issue, a set of primers
Fig. 2. Expression of T antigens from full length or VHR-truncated SV40 and JCV early region in MEFs. (A) Transcripts and proteins encoded by the SV40 and JCV viral early region (ER).
Both the SV40 and JCV ER produce multiple T antigen transcripts by alternative splicing (top panel). Translation of these transcripts results in a large T (LT), small T (sT), and one or
more smaller T proteins (lower panel). Bars of the same color or pattern represent an expressed region of the proteinwithin the same reading frame, while continuous lines represent
regions that are removed due to alternative splicing of the early region pre-mRNA. Approximate sizes of the different T antigen proteins are listed. Removal of the VHR region in JCV
prevents the expression of T0165 and T0136. Both SV40 and JCV VHR truncations produce a smaller LT protein. (B) T antigen protein expression in MEFs from full length or VHR-
truncated SV40 and JCV ER. Three individual pools are shown (labeled A, B, and C) for each construct. Equivalent amounts of whole cell lysates were separated by SDS-PAGE,
transferred to PVDF, and blotted for T antigens with a mixture of SV40 (416, 419) and JCV speciﬁc antibodies (962, 2003). GAPDH, loading control. (C) T antigen transcripts ampliﬁed by
RT-PCR using primers that surround the entire open reading frame (A and B or E and B, indicated by arrows in panel A). Each band corresponds to a different T antigen transcript:
(1) SV40 sT, (2) SV40 LT, (3) SV40 LT ΔVHR, (4) JCV sT, (5) JCV LT ΔVHR, (6) JCV T0165, (7) JCV T0136, (8) JCV T0135 (9) SV40 17kT. (D) RT-PCR speciﬁc for LT and sT transcripts (using
primers C and D or F and G, indicated by the arrows in panel A). Rpl5 transcript levels were tested to verify that equal amounts of total cDNA were used for each sample.
Table 1
Protein products potentially expressed from early region
constructs. Possible protein products expressed from both
SV40.ER and SV40.ERΔVHR constructs are equivalent. Trunca-
tion of the VHR in JCV.ER removes two 30 splice sites, which
prevents expression of T0165 and T0136 proteins.
Expected Protein Products
SV40.ER SV40.ERΔVHR
Large T Large T ΔVHR
Small T Small T
17kT 17kT
JCV.ER JCV.ERΔVHR
Large T Large T ΔVHR
Small T Small T
T0165 T0135
T0136
T0135
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designed to amplify only LT, sT, or unspliced transcripts was used
for RT-PCR (Fig. 2A, primers F and G), and both LT and sT
transcripts were detected in the JCV.ER samples (Fig. 2D, JCV ER
lanes). Removal of the VHR from JCV early region resulted in a
decrease in LT protein (Fig. 2B, lanes 10–12) but, there was no
signiﬁcant change in the level of LT mRNA (Fig. 2D, compare JCV.
ER to JCV.ERΔVHR lanes). Similar to JC.ER pools, the total level of
smaller T antigens was higher than LT in JCV.ERΔVHR-expressing
cells for both protein and mRNA (Fig. 2B, lanes 10–12; Fig. 2C, JCV
ERΔVHR lane).
The identity of smaller T antigen proteins expressed from JCV.
ER and JCV.ERΔVHR was difﬁcult to discern by migration in SDS-
PAGE. Instead, cDNA size analysis and sequencing revealed that
JCV.ER pools expressed sT and all three T0 transcripts, while JCV.
ERΔVHR pools produced only sT and T0135 transcripts due to the
deletion (Fig. 2C and D and data not shown).
Under our experimental conditions, the level of LT protein was
similar between SV40 and JCV ER-expressing cell pools (Fig. 2B,
compare lanes 1–3 with lanes 7–9). However, expression of the
VHR truncated JCV LT appeared to be higher than that observed for
SV40 LTΔVHR in the corresponding pools (Fig. 2B, compare lanes
4–6 with lanes 10–12), and the expression of both truncated LT
proteins was comparatively reduced to that of their full length
counterparts (Fig. 2B).
Growth in low serum conferred by SV40 is hindered by removal
of the VHR
MEFs respond to a reduction in serum levels in culture medium
by ceasing proliferation and eventually dying (Fig. 3A and D and
data not shown), but unrestricted growth in normal (10%) or low
(1%) serum conditions takes place in the presence of some
oncogenes, including SV40 LT. All T antigen-expressing MEFs grew
similarly in 10% serum (Fig. 3B–D), and the expression of either
SV40.ER or JCV.ER allowed proliferation of MEFs at a similar rate in
1% serum (Fig. 3B–D). Truncation of the VHR from the JCV early
region did not signiﬁcantly alter the rate of cell growth in low
serum (Fig. 3C and D). On the other hand, SV40.ERΔVHR was
unable to allow cell growth in low serum. These cells doubled only
once during the low serum treatment, similar to wild-type MEFs,
whereas all other T antigen-expressing cells doubled at least twice
while cultured in low serum for the same amount of time (Fig. 3B
and C). Furthermore, the doubling time for the SV40.ERΔVHR
MEFs was greater than that of all the other T antigen-expressing
cells (Fig. 3D). We did not ﬁnd any difference in the level of large
T antigen expressed in cells cultured in low serum compared to
those in normal serum for either SV40. ER or SV40.ERΔVHR cells
(data not shown).
Truncation of the JCV VHR region enhances anchorage independent
transformation
Both SV40 and JCV early regions have independently been
shown to induce anchorage independent growth. We analyzed the
ability of full length and VHR-truncated viral early regions to
induce this phenotype in MEFs. As expected, control MEF cells
were unable to form a signiﬁcant number of colonies when grown
Fig. 3. SV40.ERΔVHR-expressing MEFs show limited growth in reduced serum
conditions. Cells were grown in medium containing either 10% or 1% serum for up
to 12 days. Duplicate wells were counted at regular intervals and averaged. Two
experiments performed with wild-type MEFs are shown separately (A). For SV40
(B) and JCV samples (C), each point on the graph represents the average number of
cells from 3 different cell pools expressing the same early region construct. Error
bars denote the standard error of the mean. The doubling time was calculated from
time points within the exponential phase of growth and the results are summar-
ized in (D). Each value represents the average doubling time from 3 cell pools
expressing the same early region construct. MEF values are the average of
2 independent experiments. The standard error of the mean is indicated.
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in agar suspension, but expression of all early region constructs
resulted in formation of many colonies (Fig. 4A). In addition, the
size of colonies formed in all early region expressing pools was
signiﬁcantly larger than colonies formed by control MEFs (Fig. 4B
and C).
We found that SV40.ER pools generated three times more
colonies than JCV.ER pools (Fig. 4A), and also showed a higher
frequency of extremely large outlier colonies (Fig. 4B). However,
the overall distribution of colony sizes was not signiﬁcantly
different between cells expressing these two constructs (Fig. 4C).
This is consistent with previous reports using anchorage indepen-
dence assays to compare SV40 and JCV T antigen transformation
properties (Hayashi et al., 2001; Bollag et al., 1989; Trowbridge and
Frisque, 1993).
MEFs expressing the SV40 early region with or without the
VHR showed similar numbers and sizes of anchorage independent
colonies (Fig. 4A–C). On the other hand, removal of the VHR from
JCV early region induced an increase in the number of colonies by
more than 3 fold compared to cells expressing full length JCV early
region (Fig. 4A). Furthermore, the size for JCV.ERΔVHR colonies
was signiﬁcantly larger than that observed for JCV.ER colonies
(Fig. 4B–D). This was reﬂected in both an overall increase in the
number of large-sized colonies and in the high frequency of
extremely large outlier colonies found in JCV.ERΔVHR cell pools
(Fig. 4B).
The VHR region is not required to interfere with the pRB pathway
We assessed the ability of ERΔVHR products to perturb the pRB
and p53 pathways, as both must be inhibited for full LT-mediated
transformation to occur. Two markers were used to evaluate the
integrity of the pRB pathway. First, western blot analysis was
Fig. 4. Removal of the VHR in JCV TAg increases anchorage independent colony formation. Cells expressing different T antigens were suspended in agar medium, allowed to
grow for 21 days, and all single cell and multi-cell events were counted and measured as described in the Methods section. (A) The number of colonies was divided by the
total number of events to produce the percent of AI colonies per experiment. The average percent of AI colony formation for at least two pools expressing the same T antigen
is shown. Error bars represent 2 times the standard error of the mean. (B) The sizes of AI colonies from all experiments of the indicated cell type were pooled and are shown
in box-and-whisker format. The horizontal black line within the box represents the median colony size for each population. Extremely large individual outlier colonies are
shown as open circles outside of the whiskers. (C) All possible pairs of cell populations from (B) were tested to determine if the distribution of AI colony sizes between the
two cell types was signiﬁcantly different. The P-value from each test is displayed in the table. P-values less than 0.05 were considered signiﬁcant. (D) An image of the largest
colony and a median-sized colony for each TAg-expressing population is presented. All images were taken at the same magniﬁcation. Images of median sized colonies were
digitally magniﬁed to better visualize the colony. Scale bar indicates 200 μm.
Fig. 5. Removal of the VHR does not alter the ability of T antigens to disrupt the
pRB pathway. (A) Steady state levels of p130 decrease in MEFs upon expression of
either ER or ERΔVHR constructs, as monitored by Western blot. GAPDH was used as
a loading control. (B) E2F-target gene expression is increased in all T antigen-
expressing MEFs. The expression of four E2F-regulated genes was assessed by
RT-PCR of RNA from 2 days post-conﬂuent cells. Pcna: proliferating cell nuclear
antigen; Dhfr: dihydrofolate reductase; Mcm3: minichromosome maintenance
complex component 3; Cdc6: cell division cycle 6. Rpl5 is an endogenous control.
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employed to assess the steady-state levels of the cellular protein
p130, a member of the pRB family of proteins, which is reduced
upon binding to SV40 LT (Lin and DeCaprio, 2003; Stubdal et al.,
1996, 1997). Levels of p130 in all ER- and ERΔVHR-expressing
MEFs were decreased compared to control MEFs (Fig. 5A). Next,
we examined the expression levels of E2F target genes, which are
increased as a downstream effect of LT inhibition of pRB proteins
(Cantalupo et al., 2009). RT-PCR showed an increase in the level of
transcript of a set of canonical E2F-dependent genes in all cells
expressing ER or ERΔVHR constructs when compared with non-
proliferating MEFs (Fig. 5B). These combined results suggest that
the pRB pathway is effectively inhibited in all SV40 and JCV ER-
expressing cells, irrespective of VHR truncation or level of LT
produced.
p53 is bound and stabilized in all T antigen expressing MEFs
Inactivation of the p53 pathway by LT is critical to induce most
transformation phenotypes. One of the consequences of LT expres-
sion is the accumulation of p53 protein to very high levels in the
cell. However, this p53 product is not functional, as LT binds the
DNA binding domain of p53 and so prevents it from activating
genes whose expression would lead to cell death (Lilyestrom et al.,
2006; Segawa et al., 1993; Jiang et al., 1993). All ER- and ERΔVHR-
expressing MEFs showed increased levels of p53 when compared
to wild-type MEFs and MEFs treated with doxorubicin, a DNA
damaging agent and inducer of p53 (Fig. 6) (Lorenzo et al., 2002;
Attardi et al., 2004). Although lower levels of total p53 were
observed in cells expressing SV40.ERΔVHR when compared with
SV40.ER pools, this decrease is consistent with the corresponding
decrease in the amount of LT (Fig. 6, compare lanes 3–5 with 6–8).
In contrast, there was an increase in total p53 levels in JCV.
ERΔVHR pools in comparison to JCV.ER pools, but in this case
the LT expression levels remained similar or were slightly
decreased when the VHR was removed (Fig. 6, compare lanes
9–11 to 12–14). Despite the observed differences regarding total
p53 levels attained in these cells, the ability of large T antigen to
bind p53 – with or without the VHR – was conserved in both SV40
and JCV as shown by immunoprecipitation (Fig. 7).
In cells transformed by SV40 LT, the p53 protein bound by the
large T antigen shows post-translational markers of activation
(Borger and DeCaprio, 2006). We assessed the activation state of
p53 in cells expressing the SV40 or JCV ER and ERΔVHR by
examining K379 acetylation and S15 phosphorylation by western
blot. Control MEFs were treated with doxorubicin as a positive
control for p53 activation. Doxorubicin-treated cells showed a
signiﬁcant increase in both post-translational modiﬁcations of p53
when compared to untreated MEFs (Fig. 6, compare lanes 1 and 2).
SV40.ER pools produced the highest levels of acetylated and
phosphorylated p53 (Fig. 6, lanes 3–5). Similar to the total levels
of p53, the amount of post-translationally modiﬁed p53 was
decreased when the VHR was removed from SV40 (Fig. 6, lanes
6–8). JCV.ER-expressing cells displayed a very low level of K379
acetylation and S15 phosphorylation of p53 (Fig. 6, lanes 9–11).
Cells expressing the VHR truncated JCV early region showed
increased levels of post-translationally modiﬁed p53 compared
to full length JCV early region pools (Fig. 6, compare lanes 9–11
and 12–14), although these levels did not reach those observed in
SV40.ER pools (Fig. 6, compare lanes 12–14 and 3–5). At present, it
is unclear if variations in the p53 levels and modiﬁcations have a
role in tumor induction by T antigens.
Discussion
Previous studies have indicated that SV40 LT VHR contributes
to productive infection by allowing viral growth in different host
cells (Pipas, 1985; Tornow and Cole, 1983; Cole and Stacy, 1987),
and is required to permit growth of adenovirus in normally
restrictive cells (Cole et al., 1979). While early studies suggested
that the SV40 VHR is not required for immortalization or dense
focus formation in rodent cells (Tevethia et al., 1988; Pipas et al.,
1983), it remained to be seen whether this region contributes to
other transformation phenotypes. SA12, BKV and JCV polyoma-
virus LTs also have a VHR, but their roles in viral infection or
transformation have not been well studied. Though these 3 VHR
sequences are highly conserved, there is little conservation with
the SV40 VHR except for a stretch of 18 amino acids within the
Fig. 6. p53 is stabilized and shows different levels of activation in full length and
VHR-truncated early region expressing MEFs. Steady-state levels of total and post-
translationally modiﬁed p53 protein were detected by western blot in T antigen
expressing cells. Large T antigen levels were detected with a combination of SV40-
and JCV-speciﬁc antibodies (see Methods section) and are included for comparison.
MEFs treated with doxorubicin were used as a positive control for p53 stabilization
and activation. GAPDH, loading control.
Fig. 7. VHR truncated large T antigens retain the ability to bind p53. Protein
extracts were immunoprecipitated with a p53-speciﬁc antibody (PAb 421, SV40.ER
and SV40.ERΔVHR samples) or a T antigen speciﬁc antibody (PAb 416, JCV.ER and
JCV.ERΔVHR samples). Co-precipitated proteins were resolved by SDS-PAGE. The
presence of large T and p53 was monitored by western blot.
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host range region. Within this homologous sequence there are
conserved residues that have been shown in SV40 to be acetylated
and that bind cellular proteins (Fig. 1C) (Poulin et al., 2004; Poulin
and DeCaprio, 2006; Welcker and Clurman, 2005; Fine et al.,
2012). Little examination of the JCV LT VHR region has been
performed. Only one report has identiﬁed a cellular protein, the
SCF ubiquitin ligase component β-TrCP1/2 (Reviriego-Mendoza
and Frisque, 2011), which binds to the variable linker of JCV LT,
and the binding motif involved is fully conserved in BKV and SA12.
None of these interactions has been tested for the ability to affect
transformation.
In order to explore contributions of the VHR to transformation,
we examined the ability of SV40 and JCV wild-type LT and LT
mutants lacking the VHR to alter the growth properties of primary
MEFs. We took advantage of the co-linearity of SV40 and JCV LT
amino acid sequences to design VHR truncations that would not
interfere with the structure of other LT domains. The full length
and truncated early regions were cloned into the same vector and
expressed from the CMV promoter. T antigen-expressing MEFs
were then characterized for the ability to grow in low serum and
to form anchorage independent colonies.
Whereas normal MEFs proliferated slowly in 10% serum, were
growth arrested in 1% serum, and could not form anchorage
independent colonies, MEFs expressing the full length SV40 ER
grew well at both serum concentrations and formed a signiﬁcant
number of AI colonies. Surprisingly, we found that cells expressing
the SV40 VHR truncation failed to grow in 1% serum, but showed
no change in the ability to induce anchorage independent trans-
formation. Some reports suggest that the degree of transformation
by LT is dependent on the level of LT expression (Trowbridge and
Frisque, 1993; Sompayrac and Danna, 1992; Price et al., 1994), and
we observed a clear decrease in LT expression from the VHR-
truncated SV40 ER, suggesting that this may contribute to the
observed decrease of growth in low serum. Alternatively, the VHR
of LT could contribute directly to growth in low serum without
affecting anchorage independence. Finally, the SV40 VHR mutant
did not disrupt the interaction of LT with Rb proteins or binding to
p53, which are required for LT to transform. However, it is possible
that the VHR truncation alters the effect of LT on Rb or p53 in some
subtle way that our tests did not detect.
In contrast to the SV40 VHR truncation, growth in low serumwas
not affected by the removal of the JCV VHR region. Both mutant and
full length JCV early regions grew at similar rates in 10% and 1%
serum. Unexpectedly, VHR truncation of the JCV ER greatly enhanced
the number and size of anchorage independent colonies compared to
the full length JCV ER. JCV LT binding to pRB and p53 proteins was
not affected by removal of the VHR, indicating that the VHR mutant
did not change one of these fundamental pathways required for
transformation. Like SV40, LT expression decreased when JCV VHR
was removed, but, unlike SV40, there was an increase of transforma-
tion, which challenges previous reports linking higher LT levels to
increased transformation. However, due to the multiple T antigen
proteins produced by the JCV early region constructs, it remains to be
determined if the altered pattern of expression of JCV T antigen
proteins, the removal of the LT VHR region itself, or a combination of
the two is responsible for the increased capacity to induce anchorage
independent transformation. For example, we show that the JCV
T0165 protein is expressed at high levels in JCV.ER cells and is absent
in JCV.ERΔVHR cells. If T0165 is growth inhibitory, then this could
explain the increase in anchorage independent growth seen in JCV.
ERΔVHR cells. More experiments are needed to address this possi-
bility as well as others.
Unfortunately, our attempts to express either SV40 or JCV VHR
region alone or in combination with full length or truncated early
regions in MEFs were not successful. Also, efforts to express and
test individual JCV T antigens were complicated by the limited life
span of MEFs. As such, we were unable to pursue complementa-
tion studies or independent characterization of the JCV T antigen
proteins or of the VHR alone.
Another possible factor contributing to the altered transforma-
tion induced by the SV40 and JCV truncated ERs is the level of p53
in the cells. For both truncated LTs, although the ability to bind p53
was not affected, the level of total, K379 acetylated, and S15
phosphorylated p53 changed depending on whether or not the
VHR was present. The changes in total and activated p53 levels
correlated with the observed changes in transformation; growth in
low serum was prevented and p53 levels were decreased when
the VHR was deleted from the SV40 early region, and removal of
the VHR from JCV early region resulted in increased anchorage
independent transformation and increased p53 levels. It is unclear
how the level of p53 in the cells would contribute to the ability to
transform since the interaction of LT with p53 is known to confer a
loss of p53 function. Our results suggest that p53 could be
acquiring a gain of function activity when in a complex with LT,
thus enhancing transformation, but further experiments are
needed to test this hypothesis.
In summary, we have reported the ﬁrst evidence linking the
VHR region to transformation by any polyomavirus T antigen.
Overall, our results indicate that the VHR from each virus early
region confers different functional capabilities in terms of trans-
formation, and that different transformation phenotypes are
probably induced by distinct molecular mechanisms. Given the
results in this report, it is possible that VHR or C-terminal tail
regions found in polyomaviruses other than SV40 may contribute
to transformation in different ways than SV40 LT.
Table 2
Primers used in the experiments described in this manuscript.
Primers for Cloning
SV40.ER F ACCATGGATAAAGTTTTAAACAGAGA
R TTATGTTTCAGGTTCAGGGG
SV40.ERΔVHR F ACCATGGATAAAGTTTTAAACAGAGAGG
R CTAAACTCCAATTCCCATAGC
JCV.ER F ACCATGGACAAAGTGCTGAATAGGG
R TTATTTTGGGGGAGGGGTCT
JCV.ERΔVHR F ACCATGGACAAAGTGCTGAATAGGG
R CTAAATGGGTCTCCCCATACCA
Primers for RT-PCR
T antigen A ACCATGGATAAAGTTTTAAACAGAGAGG
B ACCGAGGAGAGGGTTAGGGAT
C CTGACTTTGGAGGCTTCTGG
D AAGGAAAGTCCTTGGGGTCT
E ACCATGGACAAAGTGCTGAATAGGG
F GCCTGATTTTGGTACATGGAA
G ACAGCTTGACTGAGGAATGC
Pcna F AGGCTCTCAAAGACCTCATCAATG
R CCTGTTCTGGGATTCCAAGTTG
Dhfr F GTAGAGAACTCAAAGAACCACCACG
R TTTTCCTCCTGGACCTCAGAGAG
Mcm3 F CGCAGGAAGAATGAAAAGAGGG
R CTGAGGAAGCAGGAAGTGAGAGTC
Cdc6 F AGTTCTGTGCCCGCAAAGTG
R AGCAGCAAAGAGCAAACCAGG
Rpl5 F CCAAACGATTCCCTGGTTATGAC
R GACGATTCCACCTCTTCTTCTTCAC
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Methods
Plasmids
The early regions from SV40 strain 776 (GenBank accession
NC_001669) and JCV Mad-1 strain (GenBank accession
NC_001699; received from Richard Frisque) were PCR ampliﬁed
using speciﬁc primers (Table 2) and cloned into the pLenti6.
3-TOPO vector (Invitrogen) following the manufacturer's protocol.
The full length early region includes nucleotides 2691-5163 of
SV40 and 2603-5013 of JCV, while the VHR-truncated early regions
contain nucleotides 2943-5163 of SV40 and 2792-5013 of JCV.
An artiﬁcial Kozak sequence (ACC) was included before the start
codon of all constructs to ensure efﬁcient translation. The trun-
cated early region constructs required the addition of a stop codon
immediately after the early region sequence. Both insertions were
added during PCR ampliﬁcation of the viral early regions.
Cell culture and transfection
Harvest of murine embryonic ﬁbroblasts from FVB mice was
performed as previously reported (Markovics et al., 2005). MEFs
were maintained in DMEM medium supplemented with 10% FBS,
100 U/ml penicillin, and 100 mg/ml streptomycin at 37 1C in 5%
CO2. Where indicated, conﬂuent MEFs were treated with a ﬁnal
concentration of 1 mg/ml of doxorubicin (Adriamycin, Sigma) in
growth medium for 9 h. The cells were then trypsinized and
harvested for RNA or protein extraction as described below.
Plasmids were transfected into MEFs in 6-well cell culture
plates using Fugene6 (Promega) following the manufacturer's
protocol with minimal modiﬁcations. A ratio of 1 μg plasmid to
3 μl Fugene was used. Forty-eight hours after transfection, cells
were transferred to 10-cm tissue culture dishes and allowed to
recover overnight before starting selection with 2 μg/ml blastici-
din (Invitrogen). Cells were kept under selection until all mock-
transfected MEFs died. All surviving cells from an individual
transfection were pooled, and three independent pools were
generated for each plasmid construct. All experiments were
performed with cells between passages 3 and 10.
Western blot and immunoprecipitation
All cells were collected at 2 days post-conﬂuence and lysed with
either RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% Na
Deoxycholate, 1% Triton X-100, 1 mM EDTA) for western blot
analysis, or buffer containing 50 mM Hepes pH 7.9; 0.4 M KCl;
0.5 mM EDTA; 0.1% NP40 and 10% glycerol for immunoprecipitation
assays. Lysis and subsequent procedures were performed in the
presence of protease and phosphatase inhibitors (1X Calbiochem
protease inhibitor cocktail I, 1 mM pepstatin, 10 μM leupeptin,
1 mM Na3VO4, 1 mM NaF). Clariﬁed lysates were collected and
protein concentration was assessed by the Bio-Rad protein
microassay.
For western blots, equal amounts of total protein were mixed
with Laemmli buffer and heated at 95 1C for 5 min to denature
proteins. We routinely separated 15–30 μg of denatured protein by
SDS-PAGE, then transferred proteins to PVDF, and performed
western blot with indicated antibodies. To detect the different
T antigen proteins a cocktail of 4 antibodies was used: anti-JCV
T antigen speciﬁc monoclonals PAb 962 (Tevethia et al., 1992) and
PAb 2003 (Bollag et al., 2000) (both received from Richard Frisque)
and anti-SV40 T antigen monoclonal antibodies PAb 416 and PAb
419 (Harlow et al., 1981). The epitopes of JCV antibodies PAb 962
and 2003 are within amino acids 1–81, and they recognize all of
the known JCV T antigen proteins. PAb 962 can recognize SV40 LT
but not ST, while PAb 2003 does not recognize LT or ST of SV40.
The anti-SV40 antibody PAb 416 can detect SV40 LT and 17kT, but
not sT. PAb 419 recognizes LT, sT, and 17kT of SV40. This reactivity
information is described in Table 1 of reference (Bollag et al.,
2000). The following antibodies were used to detect cellular
proteins: p130 C-20 (SantaCruz sc-317x), p53 (PAb 421(49)), S15
phospho-p53 (Cell Signaling 9284S), K379 acetyl-p53 (Cell Signal-
ing 2570S), GAPDH (US Biological G8140-11).
For immunoprecipitation assays, 25 μl of Protein G Dynabeads
magnetic particles (Life Sciences) were ﬁrst incubated for an hour
at 4 1C with 50 μl of anti-p53 PAb421 hybridoma supernatant,
supplemented with PBS to achieve a ﬁnal volume of 250 μl.
Equivalent amounts of total protein extracts (50–100 μg) were
then added to the different reactions and allowed to mix for 4 h at
4 1C. Pellets containing the immunoprecipitated complexes were
retrieved with a magnetic stand and washed four times at 4 1C
with PBS plus protease inhibitors. Protein complexes were eluted
from the magnetic beads by incubation with 20 μl 0.1 M glycine
pH 2.8 for 10 min at room temperature, and were subsequently
neutralized with 2 μl 1 M Tris-HCl pH 8.0 and prepared for SDS-
PAGE electrophoresis.
Growth assays in variable serum conditions
3104 cells were seeded onto 6-well tissue culture plates in
DMEM þ10% FBS. Each experiment was performed in duplicate.
For the low serum assay, the medium was replaced six hours later
with DMEM þ1% FBS, after washing the cells once with PBS. Cells
for both low and normal (10%) serum assays were incubated
overnight before counting the ﬁrst time point. This was considered
time zero. Cells from two wells were counted with a hemacyt-
ometer and averaged every day (normal growth) or every other
day (low serum growth) for up to 12 days. The average number of
cells counted (y-axis) at each time point (x-axis) was plotted on a
graph and the doubling time was calculated using two time points
within the exponential growth phase according to the equation:
Doubling time¼ Tln2= lnðX2=X1Þ
where T is the incubation time in hours, X2 is the number of cells
from the later time point, and X1 is the number of cells from the
earlier time point. Doubling time was divided by 24 to convert the
value into doublings per day. Each pool expressing the same early
region construct was considered a biological replicate. Wild-type
MEFs were independently tested twice, constituting technical
replicates. The doubling times from all replicates were averaged
and the standard deviation was calculated using the Excel function
“STDEV.S”. The standard error of the mean was derived by dividing
the standard deviation by the square root of the number of
replicates.
Anchorage independence assay
1.6104 cells were suspended in 0.3% agarose (Invitrogen
Ultrapure) in growth medium on top of 0.5% agarose medium
base layer in 35-mm tissue culture dishes, as previously reported
(Sun and Taneja, 2007). All experiments were performed in
duplicate. Colony formation was observed after 21 days. The area
of all single and multi- cell events was measured. The area cut-off
value chosen (1165 μm2) to deﬁne a colony allowed for 1% or less
anchorage independent (AI) colonies in the control MEF popula-
tions. The number of colonies from each plate was divided by the
total number of cellular events to obtain the percentage of
anchorage independent colonies formed. Each pool was tested
twice and the percentages of AI colonies from both assays were
averaged. Pools expressing the same early region construct were
considered biological replicates and the percentages of AI colonies
from all three pools were averaged. One of the JCV.ER-expressing
N.T.M. Seneca et al. / Virology 468-470 (2014) 47–5654
pools (pool C) was deemed an outlier as it did not accurately
represent the behavior of JCV early region as seen in pools A and B,
or as previously reported (Hayashi et al., 2001; Bollag et al., 1989;
Trowbridge and Frisque, 1993). It was, therefore, excluded from the
analysis and the percentages of AI colonies from the remaining
two JCV.ER-expressing pools were averaged. The standard error of
the mean was calculated as for the low serum growth assay.
A comparison of the size of colonies was performed by pooling
the AI colonies from assays of the same cell type, then forming a
box and whisker plot using the R statistical software package. The
Mann–Whitney–Wilcoxon test for independent samples was
applied to each possible pair of cell types also using the R software.
The null hypothesis that the distribution of the two populations is
the same was rejected if the P-value was less than 0.05.
Reverse transcription-PCR
Standard techniques were used to extract total RNA including
the on-column DNA digestion, and to synthesize cDNA (Qiagen
RNeasy kit, Qiagen RNAse-free DNase set (Saenz-Robles et al.,
2007)). Primers used for all RT-PCRs are listed in Table 2. Ampli-
ﬁcation of T antigen speciﬁc cDNAs using primers (A and B) and
(E and B) from 1 μg of total cDNA was performed with the Roche
Expand Long Template PCR system, using buffer 1 with the
following cycling parameters: 94 1C for 3 min, then 30 cycles of
94 1C 30 s, 54 1C (AþB) or 55 1C (EþB) for 30 s, 68 1C 3 min, a ﬁnal
extension was performed at 68 1C for 10 min. Speciﬁc E2F-target
gene cDNAs or T antigen speciﬁc cDNAs (primers C and D or F
and G) were ampliﬁed from equal amounts of total cellular cDNA
by PCR using GoTaq master mix (Promega) and the corresponding
primers as previously reported (Rathi et al., 2009). Annealing
temperatures were as follows: Pcna 55 1C, Dhfr 55 1C, Mcm3
55 1C, Cdc6 55 1C, Rpl5 56 1C, T antigen (C and D) and (F and G)
55 1C. Primers used are listed in Table 2. PCR products were
separated on 2% agarose gel in 1 Tris-acetate-EDTA and stained
with ethidium bromide. Images were captured with a Fujiﬁlm LAS-
3000 imager.
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